23andMe Holding Co. (MEHCQ)
OTCMKTS
· Delayed Price · Currency is USD
4.820
-0.080 (-1.63%)
Jul 7, 2025, 9:30 AM EDT
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $134.95 million as of July 7, 2025. Its market cap has decreased by -31.18% in one year.
Market Cap
134.95M
Enterprise Value
104.22M
Revenue
189.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.82
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from 622.97M to 134.95M, a decrease of -78.34%. That is a compound annual growth rate of -28.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 134.95M | 60.72% |
| Dec 31, 2024 | 83.97M | -80.81% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 639.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 557.29M |
| American Oncology Network | 418.01M |
| Northwest Biotherapeutics | 366.72M |